BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 28373165)

  • 1. It Takes a Village to Unmask HSTL.
    Yoshida N; Weinstock DM
    Cancer Discov; 2017 Apr; 7(4):352-353. PubMed ID: 28373165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Genetic Basis of Hepatosplenic T-cell Lymphoma.
    McKinney M; Moffitt AB; Gaulard P; Travert M; De Leval L; Nicolae A; Raffeld M; Jaffe ES; Pittaluga S; Xi L; Heavican T; Iqbal J; Belhadj K; Delfau-Larue MH; Fataccioli V; Czader MB; Lossos IS; Chapman-Fredricks JR; Richards KL; Fedoriw Y; Ondrejka SL; Hsi ED; Low L; Weisenburger D; Chan WC; Mehta-Shah N; Horwitz S; Bernal-Mizrachi L; Flowers CR; Beaven AW; Parihar M; Baseggio L; Parrens M; Moreau A; Sujobert P; Pilichowska M; Evens AM; Chadburn A; Au-Yeung RK; Srivastava G; Choi WW; Goodlad JR; Aurer I; Basic-Kinda S; Gascoyne RD; Davis NS; Li G; Zhang J; Rajagopalan D; Reddy A; Love C; Levy S; Zhuang Y; Datta J; Dunson DB; Davé SS
    Cancer Discov; 2017 Apr; 7(4):369-379. PubMed ID: 28122867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatosplenic T-cell lymphoma with STAT5B and SETD2 mutations recurring as cells with NK-cell immunophenotype.
    Khodadoust M; Silva O
    Blood; 2023 Feb; 141(5):555. PubMed ID: 36729542
    [No Abstract]   [Full Text] [Related]  

  • 4. Frequent STAT5B mutations in γδ hepatosplenic T-cell lymphomas.
    Nicolae A; Xi L; Pittaluga S; Abdullaev Z; Pack SD; Chen J; Waldmann TA; Jaffe ES; Raffeld M
    Leukemia; 2014 Nov; 28(11):2244-8. PubMed ID: 24947020
    [No Abstract]   [Full Text] [Related]  

  • 5. Florid splenic γ/δ T-cell proliferation in patients with splenomegaly and cytopenias: a "high stakes" diagnostic challenge.
    Zhang S; Bayerl MG
    Hum Pathol; 2017 Aug; 66():216-221. PubMed ID: 28235627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of 17 Chinese cases.
    Lu CL; Tang Y; Yang QP; Wang M; Zhao S; Bi CF; Jiang NG; Zhang WY; Liu JP; Xu X; Liu WP
    Hum Pathol; 2011 Dec; 42(12):1965-78. PubMed ID: 21683978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ring chromosome 7 with amplification of 7q sequences in a pediatric case of hepatosplenic T-cell lymphoma.
    Shetty S; Mansoor A; Roland B
    Cancer Genet Cytogenet; 2006 Jun; 167(2):161-3. PubMed ID: 16737917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT5BN642H is a driver mutation for T cell neoplasia.
    Pham HTT; Maurer B; Prchal-Murphy M; Grausenburger R; Grundschober E; Javaheri T; Nivarthi H; Boersma A; Kolbe T; Elabd M; Halbritter F; Pencik J; Kazemi Z; Grebien F; Hengstschläger M; Kenner L; Kubicek S; Farlik M; Bock C; Valent P; Müller M; Rülicke T; Sexl V; Moriggl R
    J Clin Invest; 2018 Jan; 128(1):387-401. PubMed ID: 29200404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatosplenomegaly and large kidneys with renal failure].
    Viget N; Hachulla E; Michon-Pasturel U; Queyrel V; Hatron PY; Dorémus B; Gosselin B; Devulder B
    Rev Med Interne; 1999; 20 Suppl 2():299s-300s. PubMed ID: 10422178
    [No Abstract]   [Full Text] [Related]  

  • 10. Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations.
    Roberti A; Dobay MP; Bisig B; Vallois D; Boéchat C; Lanitis E; Bouchindhomme B; Parrens MC; Bossard C; Quintanilla-Martinez L; Missiaglia E; Gaulard P; de Leval L
    Nat Commun; 2016 Sep; 7():12602. PubMed ID: 27600764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatosplenic gammadelta T-cell lymphoma.
    Wei SZ; Liu TH; Wang DT; Cao JL; Luo YF; Liang ZY
    World J Gastroenterol; 2005 Jun; 11(24):3729-34. PubMed ID: 15968729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant lymphoma imitating hepatitis.
    Harris AC; Kornstein MJ
    Cancer; 1993 Apr; 71(8):2639-46. PubMed ID: 8453587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional consequences of the STAT5B
    de Araujo ED; Erdogan F; Neubauer HA; Meneksedag-Erol D; Manaswiyoungkul P; Eram MS; Seo HS; Qadree AK; Israelian J; Orlova A; Suske T; Pham HTT; Boersma A; Tangermann S; Kenner L; Rülicke T; Dong A; Ravichandran M; Brown PJ; Audette GF; Rauscher S; Dhe-Paganon S; Moriggl R; Gunning PT
    Nat Commun; 2019 Jun; 10(1):2517. PubMed ID: 31175292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features.
    Vega F; Medeiros LJ; Bueso-Ramos C; Jones D; Lai R; Luthra R; Abruzzo LV
    Am J Clin Pathol; 2001 Sep; 116(3):410-9. PubMed ID: 11554170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare variety of T-cell lymphoma.
    Pednekar S; Morge V; Rawal S; Korivi D; Ramteke V; Naik K
    J Assoc Physicians India; 2011 Oct; 59():667-8. PubMed ID: 22479752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases.
    Yabe M; Medeiros LJ; Tang G; Wang SA; Ahmed S; Nieto Y; Hu S; Bhagat G; Oki Y; Patel KP; Routbort M; Luthra R; Fanale MA; Bueso-Ramos CE; Jorgensen JL; Vega F; Chen W; Hoehn D; Konoplev S; Milton DR; Wistuba I; Li S; You MJ; Young KH; Miranda RN
    Am J Surg Pathol; 2016 May; 40(5):676-88. PubMed ID: 26872013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rare case of hepatosplenic γδ T-cell lymphoma expressing CD19 with ring chromosome 7 and trisomy 8.
    Jain H; Shetty D; Jain H; Sengar M; Khattry N; Subramanian PG
    Cancer Genet; 2018 Dec; 228-229():17-20. PubMed ID: 30553467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SETD2 histone modifier loss in aggressive GI stromal tumours.
    Huang KK; McPherson JR; Tay ST; Das K; Tan IB; Ng CC; Chia NY; Zhang SL; Myint SS; Hu L; Rajasegaran V; Huang D; Loh JL; Gan A; Sairi AN; Sam XX; Dominguez LT; Lee M; Soo KC; Ooi LL; Ong HS; Chung A; Chow PK; Wong WK; Selvarajan S; Ong CK; Lim KH; Nandi T; Rozen S; Teh BT; Quek R; Tan P
    Gut; 2016 Dec; 65(12):1960-1972. PubMed ID: 26338826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SETD2: an epigenetic modifier with tumor suppressor functionality.
    Li J; Duns G; Westers H; Sijmons R; van den Berg A; Kok K
    Oncotarget; 2016 Aug; 7(31):50719-50734. PubMed ID: 27191891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expect the unexpected - Loss of surface CD3 on flow cytometry in hepatosplenic T-cell lymphoma: An eye opener.
    Chauhan R; Tyagi S; Mirgh S; Mishra P; Seth T; Mahapatra M; Pati H; Saxena R
    Indian J Pathol Microbiol; 2018; 61(2):275-277. PubMed ID: 29676377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.